PASADENA, CA / ACCESSWIRE / February 4, 2020 / De Novo Software, the premier provider of both research and clinical cytometry data analysis solutions, announced today that FCS Express™ will be bundled ...
PASADENA, CA / ACCESSWIRE / October 18, 2021 / Polaris Biology, a leading innovator in single-cell technologies, and De Novo Software, a premier provider of flow cytometry data analysis solutions, ...
PARIS & CHICAGO--(BUSINESS WIRE)--METAFORA biosystems, today announces the launch of METAflow, its digital flow cytometry platform, into the RUO market. METAflow offers the power of a highly advanced ...
In recent years, antibodies have become an incredibly popular therapeutic target – with monoclonal antibodies (mAbs) becoming an ever more widely used therapy for a number of diseases, including ...
Cytek® Biosciences has expanded its Cytek® Cloud digital ecosystem with a new Cloud Analysis tool, establishing the industry’s first end-to-end platform that integrates the entire flow cytometry ...
FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based ...
Flow cytometry is an invaluable tool which is routinely used across diverse fields including immunology, oncology, metabolomics, marine biology, and extracellular vesicles. Cytek’s Full Spectrum ...
Flow cytometry remains a critical technology for the high-throughput analysis of single cells in complex populations. Attention to good analysis practices is more important than ever due to the recent ...
Flow cytometry detects and measures the chemical, fluorescent, and physical characteristics of cells and particles passing in a fluid stream. This technique analyzes cells by passing them through ...
After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...
PARIS & PHILADELPHIA--(BUSINESS WIRE)--METAFORA biosystems, a company that’s leveraging its AI-powered flow cytometry platform to generate improved IVDs and more effective cell therapies, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results